Literature DB >> 16757555

Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS.

Mei-Jou Chen1, Wei-Shiung Yang, Jehn-Hsiahn Yang, Chuhsing Kate Hsiao, Yu-Shih Yang, Hong-Nerng Ho.   

Abstract

BACKGROUND: Decreased high-density lipoprotein cholesterol (HDL-C) and sex hormone-binding globulin (SHBG) levels, and the metabolic syndrome, are all closely associated with a higher prevalence of atherosclerotic cardiovascular disease. We investigated the association between HDL-C, SHBG and the metabolic syndrome in women with polycystic ovary syndrome (PCOS). METHODS AND
RESULTS: Among 106 young Taiwanese women (mean age +/- SD, 24.9 +/- 4.8 years) with PCOS, 69 (65.1%) women had an HDL-C level <50 mg dl(-1). The level of HDL-C was highly correlated with that of serum SHBG (gamma = 0.6034, P < 0.0001). The SHBG level was significantly lower in subjects with an HDL-C <50 mg dl(-1) than that in subjects with an HDL-C > or =50 mg dl(-1). Using multiple linear regression models with adjustment for age, BMI and other anthropometric, metabolic, liver function and hormonal variables, we showed serum SHBG to be independently correlated with HDL-C. Based on logistic regression analysis with adjustment for age, the SHBG level was significantly lower in women with PCOS with the metabolic syndrome (odds ratio = 0.92, P = 0.003).
CONCLUSIONS: Low levels of SHBG in women with PCOS were associated with low levels of HDL-C, independent of insulin resistance and obesity. The SHBG level was inversely related to the occurrence of metabolic syndrome, further strengthening the potential link between SHBG levels and cardiovascular disease in women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757555     DOI: 10.1093/humrep/del175

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

Review 1.  Management of obesity in the elderly: too much and too late?

Authors:  R L Kennedy; U Malabu; M Kazi; V Shahsidhar
Journal:  J Nutr Health Aging       Date:  2008-11       Impact factor: 4.075

2.  Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Authors:  Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green
Journal:  Vasc Med       Date:  2017-01-17       Impact factor: 3.239

3.  Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease.

Authors:  Andrew J Krentz; Denise von Mühlen; Elizabeth Barrett-Connor
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

Review 4.  Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.

Authors:  A E Calogero; V Calabrò; M Catanuso; R A Condorelli; S La Vignera
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

5.  Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.

Authors:  L J Moran; H J Teede; M Noakes; P M Clifton; R J Norman; G A Wittert
Journal:  J Endocrinol Invest       Date:  2013-07-01       Impact factor: 4.256

Review 6.  Endocrine and liver interaction: the role of endocrine pathways in NASH.

Authors:  Paola Loria; Lucia Carulli; Marco Bertolotti; Amedeo Lonardo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

7.  Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women.

Authors:  Wenjing Li; Hongbo Hu; Guofang Zou; Zhanzhong Ma; Jing Liu; Fanxiang Li
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

8.  The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women.

Authors:  T G Valderhaug; J K Hertel; N Nordstrand; P O Dale; D Hofsø; J Hjelmesæth
Journal:  Diabetol Metab Syndr       Date:  2015-05-21       Impact factor: 3.320

9.  Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure.

Authors:  Djuro Macut; Marina Bačević; Ivana Božić-Antić; Jelica Bjekić-Macut; Milorad Čivčić; Snježana Erceg; Danijela Vojnović Milutinović; Olivera Stanojlović; Zoran Andrić; Biljana Kastratović-Kotlica; Tijana Šukilović
Journal:  Int J Endocrinol       Date:  2015-03-24       Impact factor: 3.257

10.  The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome.

Authors:  Mahfuz Turan; Rıfkı Ucler; Mehmet Fatih Garca; Zehra Kurdoglu; Hakan Cankaya; Abdurrahman Ayral; Nazım Bozan; Ahmet Faruk Kıroglu; Mertihan Kurdoglu
Journal:  Med Sci Monit       Date:  2016-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.